Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

43.07
BATS BZX Real-Time Price
As of 3:25pm ET
 +2.98 / +7.43%
Today’s Change
22.45
Today|||52-Week Range
46.81
+39.75%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close40.09
Today’s open39.85
Day’s range39.60 - 46.81
Volume43,817
Average volume (3 months)256,780
Market cap$1.4B
Dividend yield--
Data as of 3:25pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+27.27%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+25.14%
P/E ratio114.1
Price/Sales10.05
Price/Book8.04

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.35+2.89%
EBSEmergent BioSolution...+0.14+0.41%
INVAInnoviva Inc+0.04+0.31%
FOLDAmicus Therapeutics ...+0.25+2.48%
Data as of 3:27pm ET, 06/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts